MedTech Business intelligence supplied by GlobalData
For more information: description, contents, tables, figures click on a title below
Aricept (Alzheimer’s Disease) - Forecast and Market Analysis to 2022
Exelon (Alzheimer’s Disease) - Forecast and Market Analysis to 2022
Razadyne/Reminyl (Alzheimer’s Disease) - Forecast and Market Analysis to 2022
Namenda (Alzheimer’s Disease) - Forecast and Market Analysis to 2022
Arimenda (Alzheimer’s Disease) - Forecast and Market Analysis to 2022
Solanezumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022
Crenezumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022
TRx0237 (Alzheimer’s Disease) - Forecast and Market Analysis to 2022
MK-8931(Alzheimer’s Disease) - Forecast and Market Analysis to 2022
EVP-6124 (Alzheimer’s Disease) - Forecast and Market Analysis to 2022
Lu AE58054 (Alzheimer’s Disease) - Forecast and Market Analysis to 2022
PharmaPoint: Alzheimer’s Disease - Current and Future Players
To top
Your browser does not support inline frames or is currently configured not to display inline frames.
